APA (7th ed.) Citation

Lymperopoulos, A., Rengo, G., Zincarelli, C., Kim, J., & Koch, W. J. (2011). Adrenal Beta-Arrestin 1 Inhibition In Vivo Attenuates Post-Myocardial Infarction Progression to Heart Failure and Adverse Remodeling Via Reduction of Circulating Aldosterone Levels. Journal of the American College of Cardiology (JACC), 57(3), 356. https://doi.org/10.1016/j.jacc.2010.08.635

Chicago Style (17th ed.) Citation

Lymperopoulos, Anastasios, Giuseppe Rengo, Carmela Zincarelli, Jihee Kim, and Walter J. Koch. "Adrenal Beta-Arrestin 1 Inhibition In Vivo Attenuates Post-Myocardial Infarction Progression to Heart Failure and Adverse Remodeling Via Reduction of Circulating Aldosterone Levels." Journal of the American College of Cardiology (JACC) 57, no. 3 (2011): 356. https://doi.org/10.1016/j.jacc.2010.08.635.

MLA (9th ed.) Citation

Lymperopoulos, Anastasios, et al. "Adrenal Beta-Arrestin 1 Inhibition In Vivo Attenuates Post-Myocardial Infarction Progression to Heart Failure and Adverse Remodeling Via Reduction of Circulating Aldosterone Levels." Journal of the American College of Cardiology (JACC), vol. 57, no. 3, 2011, p. 356, https://doi.org/10.1016/j.jacc.2010.08.635.